These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20032217)

  • 21. Leishmania infantum-specific IFN-γ production in stimulated blood from dogs with clinical leishmaniosis at diagnosis and during treatment.
    Martínez-Orellana P; Marí-Martorell D; Montserrat-Sangrà S; Ordeix L; Baneth G; Solano-Gallego L
    Vet Parasitol; 2017 Dec; 248():39-47. PubMed ID: 29173539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of pro-inflammatory cytokines and iron regulatory protein 2 (IRP2) with Leishmania burden in canine visceral leishmaniasis.
    do Nascimento PR; Martins DR; Monteiro GR; Queiroz PV; Freire-Neto FP; Queiroz JW; Morais Lima AL; Jeronimo SM
    PLoS One; 2013; 8(10):e73873. PubMed ID: 24146743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis.
    Martínez-Moreno A; Moreno T; Martínez-Moreno FJ; Acosta I; Hernández S
    Vet Immunol Immunopathol; 1995 Oct; 48(3-4):209-20. PubMed ID: 8578681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of intracellular IFN-γ and IL-4 cytokines in CD4+ and CD8+ T cells in the peripheral blood of dogs naturally infected with Leishmania infantum.
    Matralis D; Papadogiannakis E; Kontos V; Papadopoulos E; Ktenas E; Koutinas A
    Parasite Immunol; 2016 Aug; 38(8):510-5. PubMed ID: 27153749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leishmania-specific isotype levels and their relationship with specific cell-mediated immunity parameters in canine leishmaniasis.
    Rodríguez-Cortés A; Fernández-Bellón H; Ramis A; Ferrer L; Alberola J; Solano-Gallego L
    Vet Immunol Immunopathol; 2007 Apr; 116(3-4):190-8. PubMed ID: 17321600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dogs vaccinated with gentamicin-attenuated Leishmania infantum or infected with wild-type parasite can be distinguished by Western blotting.
    Daneshvar H; Mahmmodi Z; Kamiabi H; Phillips RS; Burchmore R
    Parasite Immunol; 2014 May; 36(5):218-24. PubMed ID: 24611833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental canine leishmaniasis: evolution of infection following re-challenge with Leishmania infantum.
    Santos-Gomes GM; Capela MJ; Ramada J; Campino L
    Acta Trop; 2003 Jul; 87(2):235-44. PubMed ID: 12826299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
    Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
    Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canine Leishmania vaccines: still a long way to go.
    Gradoni L
    Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoprophylactic Potential of a New Recombinant
    Pessoa-E-Silva R; Trajano-Silva LAM; Vaitkevicius-Antão V; Dos Santos WJT; Magalhães FB; Moura DMN; Nakasone EKN; de Lorena VMB; de Paiva-Cavalcanti M
    Front Immunol; 2020; 11():605044. PubMed ID: 33488607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected population.
    Nakhaee A; Taheri T; Taghikhani M; Mohebali M; Salmanian AH; Fasel N; Rafati S
    Vet Parasitol; 2004 Jan; 119(2-3):107-23. PubMed ID: 14746971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic progression of canine leishmaniosis following vertical transmission in United States dogs.
    Vida B; Toepp A; Schaut RG; Esch KJ; Juelsgaard R; Shimak RM; Petersen CA
    Vet Immunol Immunopathol; 2016 Jan; 169():34-8. PubMed ID: 26827836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites.
    Deplazes P; Smith NC; Arnold P; Lutz H; Eckert J
    Parasite Immunol; 1995 Sep; 17(9):451-8. PubMed ID: 8552413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination with a CD4
    Dias DS; Ribeiro PAF; Martins VT; Lage DP; Costa LE; Chávez-Fumagalli MA; Ramos FF; Santos TTO; Ludolf F; Oliveira JS; Mendes TAO; Silva ES; Galdino AS; Duarte MC; Roatt BM; Menezes-Souza D; Teixeira AL; Coelho EAF
    Transl Res; 2018 Oct; 200():18-34. PubMed ID: 29908151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgG subclass responses in a longitudinal study of canine visceral leishmaniasis.
    Quinnell RJ; Courtenay O; Garcez LM; Kaye PM; Shaw MA; Dye C; Day MJ
    Vet Immunol Immunopathol; 2003 Feb; 91(3-4):161-8. PubMed ID: 12586479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of three recombinant Leishmania infantum antigens in human and canine visceral leishmaniasis diagnosis.
    Fonseca AM; Faria AR; Rodrigues FT; Nagem RA; Magalhães RD; Cunha JL; Bartholomeu DC; de Andrade HM
    Acta Trop; 2014 Sep; 137():25-30. PubMed ID: 24801885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein.
    Fernandes AP; Costa MM; Coelho EA; Michalick MS; de Freitas E; Melo MN; Luiz Tafuri W; Resende Dde M; Hermont V; Abrantes Cde F; Gazzinelli RT
    Vaccine; 2008 Oct; 26(46):5888-95. PubMed ID: 18786587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses of Iranian patients with visceral leishmaniasis and recovered individuals to LCR1 of Leishmania infantum.
    Niknam HM; Abrishami F; Doroudian M; Rostamian M; Moradi M; Khaze V; Iravani D
    Clin Vaccine Immunol; 2014 Apr; 21(4):518-25. PubMed ID: 24501341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications.
    Cordeiro-da-Silva A; Cardoso L; Araújo N; Castro H; Tomás A; Rodrigues M; Cabral M; Vergnes B; Sereno D; Ouaissi A
    Immunol Lett; 2003 Apr; 86(2):155-62. PubMed ID: 12644317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs.
    Saldarriaga OA; Travi BL; Park W; Perez LE; Melby PC
    Vaccine; 2006 Mar; 24(11):1928-40. PubMed ID: 16310897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.